Publications

Detailed Information

Postoperative Nomogram Predicting Risk of Recurrence After Radical Hysterectomy for Early-Stage Cervical Cancer

DC Field Value Language
dc.contributor.authorKim, Mi-Kyung-
dc.contributor.authorJo, Hoenil-
dc.contributor.authorKong, Hyoun-Joong-
dc.contributor.authorKim, Hee Chan-
dc.contributor.authorKim, Yong-Man-
dc.contributor.authorKang, Soon-Beom-
dc.contributor.authorLee, Hyo Pyo-
dc.contributor.authorMok, Jung-Eun-
dc.contributor.authorSong, Yong-Sang-
dc.contributor.authorKim, Jae Weon-
dc.date.accessioned2012-06-04T06:34:35Z-
dc.date.available2012-06-04T06:34:35Z-
dc.date.issued2010-12-
dc.identifier.citationINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER; Vol.20 9; 1581-1586ko_KR
dc.identifier.issn1048-891X-
dc.identifier.urihttps://hdl.handle.net/10371/76794-
dc.description.abstractObjective: The aim of this study was to develop a nomogram for predicting the 5-year disease-free survival (DFS) after radical hysterectomy for early-stage cervical cancer. Patients and Methods: An institutional database of 275 consecutive patients treated at Seoul National University Hospital for stage I to stage IIA cervical cancer was used to develop a nomogram based on Cox proportional hazards regression model. The developed nomogram was internally validated with bootstrapping, and performance was assessed by concordance index and a calibration curve. External validation was also performed using an independent data set of patients from Asan Medical Center. Results: From Cox regression analysis, disease stage, number of positive lymph nodes, parametrial involvement, and depth of invasion were identified as independent risk factors for disease recurrence (P < 0.05). The nomogram incorporating these factors appeared to be accurate and predicted the outcomes better than the International Federation of Gynecology and Obstetrics stage alone (concordance index, 0.858 compared with 0.719; P = 0.001). When applied to a separate validation set, the nomogram also showed similar predictive accuracy (concordance index, 0.879). Conclusion: We have developed a nomogram that can predict the recurrence risk in patients with early-stage cervical cancer after surgery, which was internally and externally validated.ko_KR
dc.language.isoenko_KR
dc.publisherLIPPINCOTT WILLIAMS & WILKINSko_KR
dc.subjectCervical cancerko_KR
dc.subjectRadical hysterectomyko_KR
dc.subjectPrognosisko_KR
dc.subjectNomogramko_KR
dc.titlePostoperative Nomogram Predicting Risk of Recurrence After Radical Hysterectomy for Early-Stage Cervical Cancerko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김미경-
dc.contributor.AlternativeAuthor조헌일-
dc.contributor.AlternativeAuthor공현중-
dc.contributor.AlternativeAuthor김희찬-
dc.contributor.AlternativeAuthor김재원-
dc.contributor.AlternativeAuthor김용만-
dc.contributor.AlternativeAuthor송용상-
dc.contributor.AlternativeAuthor강순범-
dc.contributor.AlternativeAuthor목정은-
dc.contributor.AlternativeAuthor이효표-
dc.identifier.doi10.1111/IGC.0b013e3181f7b353-
dc.citation.journaltitleINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER-
dc.description.citedreferenceShibata K, 2008, INT J CLIN ONCOL, V13, P233, DOI 10.1007/s10147-007-0744-0-
dc.description.citedreferenceIasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791-
dc.description.citedreferenceChi DS, 2008, GYNECOL ONCOL, V108, P191, DOI 10.1016/j.ygyno.2007.09.020-
dc.description.citedreferenceKIM K, 2008, J GYNECOL ONCOL, V19, P209, DOI 10.3802/jgo.2008.19.4.209-
dc.description.citedreferenceSHIN HR, 2007, CANC RES TREAT, V39, P139-
dc.description.citedreferenceChung HH, 2006, INT J GYNECOL CANCER, V16, P1833, DOI 10.1111/j.1525-1438.2006.00708.x-
dc.description.citedreferenceSternberg CN, 2006, J CLIN ONCOL, V24, P3819, DOI 10.1200/JCO.2006.07.1290-
dc.description.citedreferenceRouzier R, 2006, OBSTET GYNECOL, V107, P672-
dc.description.citedreferenceStephenson AJ, 2005, J CLIN ONCOL, V23, p389S-
dc.description.citedreferenceParkin DM, 2005, CA-CANCER J CLIN, V55, P74-
dc.description.citedreferenceRyu HS, 2005, GYNECOL ONCOL, V96, P490, DOI 10.1016/j.ygyno.2004.10.038-
dc.description.citedreferenceHo CM, 2004, GYNECOL ONCOL, V93, P458, DOI 10.1016/j.ygyno.2004.01.026-
dc.description.citedreferenceVan Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015-
dc.description.citedreferenceBenedet JL, 2003, INT J GYNECOL OBSTET, V83, P41-
dc.description.citedreferenceKattan MW, 2002, J CLIN ONCOL, V20, P791-
dc.description.citedreferenceEASTHAM JA, 2002, SEMIN UROL ONCOL, V20, P108-
dc.description.citedreferenceVergote I, 2002, INT J GYNECOL CANCER, V12, P22-
dc.description.citedreferencePeters WA, 2000, J CLIN ONCOL, V18, P1606-
dc.description.citedreferenceSedlis A, 1999, GYNECOL ONCOL, V73, P177-
dc.description.citedreferenceRussell AH, 1998, INT J RADIAT ONCOL, V40, P605-
dc.description.citedreferenceLandoni F, 1997, LANCET, V350, P535-
dc.description.citedreferenceShingleton HM, 1996, J AM COLL SURGEONS, V183, P393-
dc.description.citedreferenceSevin BU, 1996, CANCER, V78, P1438-
dc.description.citedreferenceDELGADO G, 1990, GYNECOL ONCOL, V38, P352-
dc.description.citedreferenceBARTER JF, 1989, GYNECOL ONCOL, V32, P292-
dc.description.citedreferenceGAUTHIER P, 1985, OBSTET GYNECOL, V66, P569-
dc.description.citedreferenceBOYCE J, 1981, GYNECOL ONCOL, V12, P154-
dc.description.citedreferenceCHUNG CK, 1980, AM J OBSTET GYNECOL, V138, P550-
dc.description.citedreferenceLAGASSE LD, 1980, GYNECOL ONCOL, V9, P90-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share